Abstract:Objective: Amyotrophic lateral sclerosis (ALS) is an incurable, progressive neurodegenerative disease with a significant health burden and poorly understood etiology. This analysis assessed the narrative responses from 3,061 participants in the Centers for Disease Control and Prevention's National ALS Registry who answered the question, "What do you think caused your ALS?" Methods: Data analysis used qualitative methods and artificial intelligence (AI) using natural language processing (NLP), specifically, Bidirectional Encoder Representations from Transformers (BERT) to explore responses regarding participants' perceptions of the cause of their disease. Results: Both qualitative and AI analysis methods revealed several, often aligned themes, which pointed to perceived causes including genetic, environmental, and military exposures. However, the qualitative analysis revealed detailed themes and subthemes, providing a more comprehensive understanding of participants' perceptions. Although there were areas of alignment between AI and qualitative analysis, AI's broader categories did not capture the nuances discovered using the more traditional, qualitative approach. The qualitative analysis also revealed that the potential causes of ALS were described within narratives that sometimes indicate self-blame and other maladaptive coping mechanisms. Conclusions: This analysis highlights the diverse range of factors that individuals with ALS consider as perceived causes for their disease. Understanding these perceptions can help clinicians to better support people living with ALS (PLWALS). The analysis highlights the benefits of using traditional qualitative methods to supplement or improve upon AI-based approaches. This rapidly evolving area of data science has the potential to remove barriers to accessing the rich narratives of people with lived experience.

What problem does this paper attempt to address?

### What problems does this paper attempt to solve? This paper aims to explore and analyze the qualitative risk factor data in the National Amyotrophic Lateral Sclerosis (ALS) Patient Registry of the US Centers for Disease Control and Prevention (CDC) to understand patients' views on the causes of their own diseases. Specifically, researchers analyzed the responses of 3,061 ALS patients through natural language processing (NLP) techniques and traditional qualitative methods. These patients were asked, "What do you think caused your ALS?" #### Research background ALS is a fatal and incurable neurodegenerative disease, and its etiology is not fully understood, which brings a huge health burden to patients. Although there have been some studies on ALS, most of them focus on genetic factors and environmental exposures, and less attention is paid to patients' own perceptions and views. Therefore, this study hopes to reveal more potential pathogenic factors by analyzing patients' self - reports and provide clinicians with better methods to support ALS patients. #### Research objectives 1. **Evaluate patients' perceptions**: Understand their views on the causes of ALS by analyzing patients' narrative responses. 2. **Compare the effects of different analysis methods**: Compare the effects of artificial intelligence (AI) and natural language processing (NLP) techniques with traditional qualitative analysis methods in revealing patients' perceptions. 3. **Identify potential risk factors**: Find out various factors that patients mentioned may be related to the onset of ALS, including genetics, environmental exposures, military experiences, etc. 4. **Understand patients' mental states**: Explore patients' emotional and psychological reactions when facing this incurable disease, such as self - blame and maladaptive coping mechanisms. #### Main findings - **Diverse perceptions**: Patients' responses showed diverse views on the causes of ALS, involving multiple factors such as genetics, environmental exposures, and lifestyles. - **Emotional and psychological impacts**: Many patients expressed emotions such as frustration, confusion, helplessness, and even self - blame. - **Complementarity between AI and qualitative analysis**: Although AI can quickly classify a large amount of data, traditional qualitative analysis can reveal details and complexity more in - depth, especially in capturing nuances. #### Conclusions This study emphasizes the importance of understanding ALS patients' perceptions of the causes of the disease, and points out that these perceptions can help clinicians better support ALS patients and their families. At the same time, the study also shows the advantages of traditional qualitative analysis methods in supplementing and improving AI - based methods. The rapid development in this field helps break down the barriers to obtaining rich patient experience data. ### Summary The main purpose of this paper is to reveal patients' diverse views on the causes of the disease and evaluate the effects of different analysis methods by analyzing ALS patients' self - reports. This not only helps to deepen the understanding of the causes of ALS, but also provides valuable insights for improving patient support and care.

What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology

How the prospect of a clinical trial impacts decision-making for predictive genetic testing in amyotrophic lateral sclerosis

Risk factors associated with amyotrophic lateral sclerosis based on the observational study: a systematic review and meta-analysis

Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines

Machine learning and brain-computer interface approaches in prognosis and individualized care strategies for individuals with amyotrophic lateral sclerosis: A systematic review

Novel Insight Into the Role of Immune Dysregulation in Amyotrophic Lateral Sclerosis Based on Bioinformatic Analysis

Patient reported impact of symptoms in amyotrophic lateral sclerosis (PRISM-ALS): A national, cross-sectional study

How the prospect of a clinical trial impacts decision-making for predictive genetic testing in ALS

Machine learning hypothesis-generation for patient stratification and target discovery in rare disease: our experience with Open Science in ALS

Improving prediction models of amyotrophic lateral sclerosis (ALS) using polygenic, pre-existing conditions, and survey-based risk scores in the UK Biobank

Harnessing Big Data in Amyotrophic Lateral Sclerosis: Machine Learning Applications for Clinical Practice and Pharmaceutical Trials

Identification of Regulatory Factors and Prognostic Markers in Amyotrophic Lateral Sclerosis

Identification of Therapeutic Targets for Amyotrophic Lateral Sclerosis Using PandaOmics – An AI-Enabled Biological Target Discovery Platform

Risk factors of amyotrophic lateral sclerosis: a global meta-summary

Prediction of caregiver quality of life in amyotrophic lateral sclerosis using explainable machine learning

Artificial intelligence for screening and diagnosis of amyotrophic lateral sclerosis: a systematic review and meta-analysis

Identifying patterns in amyotrophic lateral sclerosis progression from sparse longitudinal data

Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

Intersection of network medicine and machine learning towards investigating the key biomarkers and pathways underlying amyotrophic lateral sclerosis: a systematic review

Global Prevalence and Incidence of Amyotrophic Lateral Sclerosis

Genome-Wide and Transcriptome-Wide Association Studies on Northern New England and Ohio Amyotrophic Lateral Sclerosis Cohorts